Clinical Trials Logo

Filter by:
NCT ID: NCT03146117 Terminated - PET CT Clinical Trials

PET-DECT for Staging and Imaged Based Radiotherapy Planning in Lung Cancer

Start date: April 1, 2017
Phase:
Study type: Observational

The overall goal of this project is to investigate the diagnostic performance of integrated F-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) and Dual Energy CT (DECT) imaging in determining the thoracic nodal status of small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC), and its impact on target volume delineation for image guided radiation therapy (IGRT) planning.

NCT ID: NCT03155321 Terminated - Cholelithiasis Clinical Trials

SAGES Safe Cholecystectomy Program in Polish Reality - Awareness, Implementation and Opinion on Usefulness

Start date: April 1, 2017
Phase:
Study type: Observational

The study is designed to assess the awareness of the SAGES Safe Cholecystectomy Program among polish surgeons, as well as the degree of implementation of this Program during laparoscopic cholecystectomy performed in Poland. It also gathers the opinion of polish surgeons on usefulness of each of the SAGES Safe Cholecystectomy Rules

NCT ID: NCT03264742 Terminated - Stroke, Acute Clinical Trials

Ghrelintrial With Patients With Stroke

Start date: April 1, 2017
Phase:
Study type: Observational

Patients are assigned to KSW's Stroke Unit as part of the emergency treatment. There the patients are included in the study and treated according to the concept on the Stroke Unit within the complex treatment. The patients are included after clarification and with the consent of the patients. On the morning after the day of intake, the first determination of the ghrelin takes place in the routine blood sampling. Similarly, 48 hours later and 3 months after the stroke, a blood sampling is performed to determine ghrelin. The De Morton Mobility Index (DEMMI), the 9-hole-peg assay and the modified Rankin Scale (mRS) are determined on the day of admission, on the 3rd day, and three months after stroke. This is done within the framework of the routine clarification and treatment on the Stroke Unit.

NCT ID: NCT03268278 Terminated - Postoperative Pain Clinical Trials

Efficacy of Buprenorphine on Postoperative Endodontic Analgesia

EBPEA
Start date: April 1, 2017
Phase: Phase 1
Study type: Interventional

To see whether the addition of buprenorphone to local anesthesia will lengthen postoperative analgesia for endodontic pain

NCT ID: NCT03354260 Terminated - Nutrition Clinical Trials

Optimization of Oral Diet in Critically Ill Patients

NAP-REA
Start date: April 1, 2017
Phase: N/A
Study type: Interventional

The purpose of the present study is to evaluate the effects of a personalized oral diet in the critically ill patients during ICU stay and after as compared usual oral diet.

NCT ID: NCT02290119 Terminated - Osteoarthritis Clinical Trials

Gait and Functional Improvement in Total Knee Arthroplasty With the Use of Verasense for Soft Tissue Balancing

Start date: April 1, 2018
Phase: N/A
Study type: Interventional

The primary objectives of this study are to understand the effects of soft-tissue balancing on Gait, function and rehabilitation potential after sensor-assisted Total Knee Arthroplasty and correlate Intra-operative subjective feel with OrthoSensor Outputs Secondary objectives are to quantify and observe: - Pain medication use - Swelling - Muscle strength and girth - Gait efficiency - Patient satisfaction - Activity levels, functional return (i.e., back to work, resume normal activities) - Patient perception of a balanced knee

NCT ID: NCT03089502 Terminated - Breast Cancer Clinical Trials

Efficacy of Cardio-Oncology Rehabilitation Exercise for Women With Breast Cancer and Treatment Related Cardiotoxicity

CORE
Start date: April 1, 2018
Phase: N/A
Study type: Interventional

Breast cancer is the leading cause of cancer among Canadian women with nearly 26,000 new cases diagnosed each year. Fortunately, advancements in diagnostic tools and curative treatments have significantly improved overall survival. However, the development of cardiac toxicity (including asymptomatic and symptomatic heart failure) associated with use of anthracycline containing chemotherapy and targeted therapies including trastuzumab limits improvements in survival for women with breast cancer. Cardiac toxicity is a life threatening complication that leads to reduced physical functioning and quality of life. The increased risk is associated with shared risk factors among cancer and heart failure and the direct influence of cancer therapy on the cardiovascular system. Cardiac rehabilitation (CR) (including exercise training and education/counselling) has been shown to improve health outcomes, reduce heart failure related hospitalizations and modestly improve mortality among individuals with non-treatment related heart failure and may benefit women with breast cancer and treatment related cardiac toxicity (BC-CT). Therefore, this single centre, randomized control trial aims to determine if participation in an exercise based CR program can improve cardiorespiratory fitness, cardiovascular function/structure and health, and quality of life among women with BC-CT.

NCT ID: NCT03362671 Terminated - Clinical trials for Obstructive Sleep Apnea

Implant Supported Oral Appliance Treatment of OSA

BIMA
Start date: April 1, 2018
Phase: N/A
Study type: Interventional

Mandibular advancing oral appliances (OAm) are an effective and increasingly common treatment modality for the management of obstructive sleep apnea (OSA) in adults. The effectiveness of OAm therapy, however, is dependent on a high level of patient adherence, which may be negatively impacted by treatment side effects - the most significant of which are occlusal changes and tooth movement. The proposed pilot study will evaluate the efficacy of a novel implant supported OAm in 10 OSA patients who have already been successfully treated with a traditional OAm. The study will compare OSA specific outcomes with traditional OAm use against novel oral appliance use after one month. This study could potentially validate the novel design features of an effective treatment option for OSA that does not result in tooth movement, which is a significant side effect shared by all existing OAm devices. Ultimately, this study could lead to increased treatment adherence and better OSA patient health outcomes in the future.

NCT ID: NCT03424512 Terminated - Depression Clinical Trials

Group Metacognitive Therapy for Anxiety and Depression in Cancer Survivors

GMAC
Start date: April 1, 2018
Phase: N/A
Study type: Interventional

This study aims to test the potential of group metacognitive therapy in alleviating emotional distress in cancer survivors. The investigators aim to find out if a group based approach is acceptable to patients and feasible to deliver in a routine clinical health psychology service.

NCT ID: NCT03433937 Terminated - Quality of Life Clinical Trials

Prevention of Seroma Following Inguinal Lymph Node Dissection With Prophylactic Incisional Negative Pressure Wound Therapy

Start date: April 1, 2018
Phase: N/A
Study type: Interventional

Inguinal lymph node dissection (ILND) is indicated following metastatic malignant melanoma, and is associated with a high-complication rate, of which many begin with the formation of seroma and ends in complicated wound healing, reoperation, multiple outpatient visits and re-hospitalization. Prevention of seroma may therefore lead to a reduction of many of the preceding complications and improve patient quality-of-life. The aim of this study is to evaluate the efficacy and oncological safety of prophylactic negative pressure wound therapy following ILND in melanoma patients.